87 related articles for article (PubMed ID: 24119764)
1. Bone morphogenic protein-4: a potential novel target for preventing vein graft failure in coronary revascularization.
Hu J; Zhao JJ
Med Hypotheses; 2013 Dec; 81(6):1025-8. PubMed ID: 24119764
[TBL] [Abstract][Full Text] [Related]
2. [The Association Between Bone Morphogenic Protein-4 and
Zhang HW; Gu J; Zhang EY; Guo YQ; Wu Z; Gan CP; Fan KJ; Xiao ZH; Hu J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 47(5):738-742. PubMed ID: 28598090
[TBL] [Abstract][Full Text] [Related]
3. External support in preventing vein graft failure.
Hu J; Wan S
Asian Cardiovasc Thorac Ann; 2012 Oct; 20(5):615-22. PubMed ID: 23087319
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenic protein-4 contributes to venous endothelial dysfunction in patients with diabetes undergoing coronary revascularization.
Hu J; Liu J; Kwok MW; Wong RH; Huang Y; Wan S
Ann Thorac Surg; 2013 Apr; 95(4):1331-9. PubMed ID: 23522199
[TBL] [Abstract][Full Text] [Related]
5. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions.
Harskamp RE; Lopes RD; Baisden CE; de Winter RJ; Alexander JH
Ann Surg; 2013 May; 257(5):824-33. PubMed ID: 23574989
[TBL] [Abstract][Full Text] [Related]
6. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath.
Vijayan V; Shukla N; Johnson JL; Gadsdon P; Angelini GD; Smith FC; Baird R; Jeremy JY
J Vasc Surg; 2004 Nov; 40(5):1011-9. PubMed ID: 15557918
[TBL] [Abstract][Full Text] [Related]
7. The lima success story--whither other arterial grafts--are vein grafts obsolete?
Cooper GJ; Underwood MJ; Deverall PB
Br J Clin Pract; 1996; 50(3):144-50. PubMed ID: 8733333
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 and vein graft occlusion in patients undergoing bypass surgery.
Dashwood MR
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():78-87. PubMed ID: 19335750
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic inhibition of vein graft neointimal hyperplasia.
Schachner T
J Thorac Cardiovasc Surg; 2006 May; 131(5):1065-72. PubMed ID: 16678591
[TBL] [Abstract][Full Text] [Related]
10. Fractional flow reserve-guided coronary artery bypass grafting: can intraoperative physiologic imaging guide decision making?
Ferguson TB; Chen C; Babb JD; Efird JT; Daggubati R; Cahill JM
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):824-835.e1. PubMed ID: 23915918
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy and coronary artery bypass grafting: current perspectives.
George SJ; Channon KM; Baker AH
Curr Opin Mol Ther; 2006 Aug; 8(4):288-94. PubMed ID: 16955691
[TBL] [Abstract][Full Text] [Related]
12. Clinical alternative bypass conduits and methods for surgical coronary revascularization.
Nishida H; Grooters RK; Soltanzadeh H; Thiemen KC; Schneider RF
Surg Gynecol Obstet; 1991 Feb; 172(2):161-74. PubMed ID: 1671177
[TBL] [Abstract][Full Text] [Related]
13. Influence of vein graft use on postoperative 1-year results after off-pump coronary artery bypass surgery.
Cho KR; Jeong DS; Kim KB
Eur J Cardiothorac Surg; 2007 Nov; 32(5):718-23. PubMed ID: 17822913
[TBL] [Abstract][Full Text] [Related]
14. On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents.
Jeremy JY; Gadsdon P; Shukla N; Vijayan V; Wyatt M; Newby AC; Angelini GD
Biomaterials; 2007 Feb; 28(6):895-908. PubMed ID: 17113144
[TBL] [Abstract][Full Text] [Related]
15. [The Role of Bone Morphogenic Protein-4 in the Progression of Vein Graft Hyperplastic Remodeling under Hyperglycemic Condition].
Fang DF; Zhang HW; Gu J; Fan KJ; Liang HM; Shen JY; Zhang EY; Hu J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 48(5):710-715. PubMed ID: 29130662
[TBL] [Abstract][Full Text] [Related]
16. Arterial versus venous bypass grafts in patients with in-stent restenosis.
Gaudino M; Cellini C; Pragliola C; Trani C; Burzotta F; Schiavoni G; Nasso G; Possati G
Circulation; 2005 Aug; 112(9 Suppl):I265-9. PubMed ID: 16159829
[TBL] [Abstract][Full Text] [Related]
17. Role of the renin-angiotensin system in the pathogenesis of intimal hyperplasia: therapeutic potential for prevention of vein graft failure?
Osgood MJ; Harrison DG; Sexton KW; Hocking KM; Voskresensky IV; Komalavilas P; Cheung-Flynn J; Guzman RJ; Brophy CM
Ann Vasc Surg; 2012 Nov; 26(8):1130-44. PubMed ID: 22445245
[TBL] [Abstract][Full Text] [Related]
18. [Histological study of saphenous vein graft disease after coronary artery bypass grafting].
Kobayashi T; Fuse K; Naruse Y; Watanabe Y; Konishi H
Nihon Kyobu Geka Gakkai Zasshi; 1993 Apr; 41(4):592-7. PubMed ID: 8515157
[TBL] [Abstract][Full Text] [Related]
19. Distal embolic protection for SVG interventions: can we afford not to use it?
Shaia N; Heuser RR
J Interv Cardiol; 2005 Dec; 18(6):481-4. PubMed ID: 16336429
[TBL] [Abstract][Full Text] [Related]
20. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention.
Motwani JG; Topol EJ
Circulation; 1998 Mar; 97(9):916-31. PubMed ID: 9521341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
